Centrient Pharmaceuticals
Shiril Oberoi's work experience includes a role as the Head of Total Rewards & HR Excellence at Centrient Pharmaceuticals starting in 2023. Before that, they worked at Cvent as a Senior Manager of Total Rewards & People Analytics from 2019 to 2023 and as a Manager of Total Rewards from 2015 to 2019. From 2011 to 2015, Shiril was a Manager of Human Resources at Toluna Corporate. Prior to that, they worked at Bajaj Capital Ltd as an Assistant Manager of HR from 2010 to 2011. Lastly, they served as an Assistant Manager of HR at Interactive Business Solutions Pvt. Ltd from 2005 to 2010, where they streamlined HR activities and managed various HR programs and operations.
Shiril Oberoi completed a BBA degree at Guru Gobind Singh Indraprastha University from 2000 to 2003. Prior to that, from 1986 to 2000, Shiril attended Hans Raj Model School where they completed their Higher Secondary education with a focus on Commerce.
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.